DiLumen Endolumenal Therapy System for Procedures Inside Large Intestine FDA Cleared

December 23rd, 2016

Lumendi, LLC, a U.S. subsidiary of Lumendi, Ltd. out of London, England, won FDA clearance for its DiLumen endolumenal therapy system. The system is designed to isolate a section of the large intestine, to position the endoscope within it for a good viewing angle, and to help with delivery of incision-free endolumenal therapies.

The DiLumen was an idea that came out of the Minimally Invasive New Technologies program (MINT) at Weill Cornell Medicine and New York-Presbyterian, and developed by MINT and Lumendi.

Read full article at http://www.medgadget.com/2016/12/dilumen-endolumenal-therapy-system-procedures-inside-large-intestine-fda-cleared.html